Physician profile
Darrell E Robins
NPI 1710984653
$3,758.07
in general payments reported to CMS, 2019-2025
40 companies · $576 in 2025
The $576 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $104 · 2021: $444 · 2022: $863 · 2023: $753 · 2024: $407 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.50 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $427.27 | 2019-2025 | |
| Abbvie INC. | $400.38 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $295.47 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $243.06 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $211.45 | 2019-2022 | |
| Hologic Sales and Service, LLC | $210.01 | 2022-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $199.72 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $182.55 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.79 | 2019-2025 | |
| Myovant Sciences INC. | $133.06 | 2021-2022 | |
| Aspira Women'S Health INC | $124.95 | 2022 | |
| Daiichi Sankyo INC. | $111.92 | 2019-2023 | Enhertu |
| Conmed Corporation | $98.05 | 2022 | |
| Organon LLC | $93.96 | 2021-2025 | Nexplanon |
| Millicent US INC | $92.43 | 2019-2025 | Intrarosa, Femring |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Robins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.